Literature DB >> 11230998

Effects of food intake and oxidative stress on intestinal lesions caused by meloxicam and piroxicam in rats.

I Villegas1, C Alarcón de la Lastra, C La Casa, V Motilva, M J Martín.   

Abstract

Large intestinal ulcers, bleeding and perforation are occasionally due to non-steroidal anti-inflammatory drugs (NSAID). In addition to suppression of prostaglandins synthesis, a number of factors have been implicated, including enterohepatic recirculation, food intake and vascular injury with oxygen free-radical generation. The present study aimed to determine the effect of food intake and the role of oxidative stress in the pathogenesis of intestinal injury induced by oral administration of meloxicam (preferential cyclooxygenase-2 inhibitor) vs. piroxicam (preferential cyclooxygenase-1 inhibitor). Therefore, the activity of oxidative stress-related enzymes such as myeloperoxidase, xanthine oxidase and superoxide dismutase, as well as levels of lipid peroxides and glutathione homeostasis were studied in an experimental model using re-fed rats. The animals treated with piroxicam (10-20 mg/kg) had a dose-dependent increase in the severity of intestinal lesions, but only the highest dose of meloxicam (15 mg/kg) caused macroscopic damage. The severity of piroxicam and meloxicam-induced damage was correlated with a significant increase of xantine oxidase activity and a decrease of superoxide dismutase activity and glutathione levels (P<0.05 and P<0.001 vs. control). In contrast, there was no significant neutrophil infiltration of the intestine after dosing. Our results support the hypothesis that oxygen free radicals, probably derived via the action of xantine oxidase, the decrease in superoxide dismutase activity, and depletion of mucosal glutathione contribute to the pathogenesis of meloxicam and piroxicam-induced intestinal ulceration in re-fed rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230998     DOI: 10.1016/s0014-2999(00)00883-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Plasma Concentration of Meloxicam in Pediatric Rats.

Authors:  Kristina A Pugh; Kyle J Reitnauer; Robyn B Lee; William L Wilkins; John H McDonough; M Ross Pennington; Samantha R Litvin
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-11-01       Impact factor: 1.232

2.  Hemodynamic and behavioral differences after administration of meloxicam, buprenorphine, or tramadol as analgesics for telemeter implantation in mice.

Authors:  Matthew T Rätsep; Valerie F Barrette; Andrew Winterborn; Michael A Adams; B Anne Croy
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

3.  Extra-virgin olive oil-enriched diets reduce indomethacin-induced gastric oxidative damage in rats.

Authors:  C Alarcón de la Lastra; M D Barranco; M J Martín; J Herrerías; V Motilva
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

4.  Ameliorative effect of ocimum sanctum on meloxicam induced toxicity in wistar rats.

Authors:  R Mahaprabhu; A G Bhandarkar; Babu Lal Jangir; S P Rahangadale; N V Kurkure
Journal:  Toxicol Int       Date:  2011-07

5.  Coenzyme Q10 supplementation mitigates piroxicam-induced oxidative injury and apoptotic pathways in the stomach, liver, and kidney.

Authors:  Ahmed Abdeen; Afaf Abdelkader; Dina Elgazzar; Mohamed Aboubakr; Omnia A Abdulah; Khaled Shoghy; Mohamed Abdel-Daim; Hamed A El-Serehy; Agnieszka Najda; Amany El-Mleeh
Journal:  Biomed Pharmacother       Date:  2020-08-28       Impact factor: 6.529

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.